Tag:
Protein Sciences
Latest Headlines
Latest Headlines
Emergent vows to continue battle over collapsed merger
A federal judge has tossed Emergent BioSolutions' attempt to force Protein Sciences into bankruptcy, but Emergent isn't about to give up on its long-running fight with Protein Sciences following the
Vaccine targets swine flu as FDA targets fakes
As the first U.S. doses of government-contracted H1N1 swine flu vaccine were produced last week-via egg-less insect cell technology-the FDA reminds the public to be wary of Internet sites and other
Protein Sciences wins $150M contract for gene-based vax program
Protein Sciences' gene-based approach to vaccine development has drawn considerable support from the federal government. The government issued a $35 million contract to the vaccine company to help
Facing angry creditors, Protein Sciences wins $35M contract
A day after creditors went to federal court in a bid to push the financially shaky vaccine maker Protein Sciences into bankruptcy liquidation, the company won a $35 million federal contract to push a
Creditors call for Protein Sciences liquidation
Two weeks after Protein Sciences announced that it had begun producing the world's first swine flu vaccine, creditors of the company filed a petition for involuntary bankruptcy. The creditors claimed
Emergent ends attempt to buy Protein Sciences
Emergent BioSolutions is walking away from its troubled attempt to finish a merger deal with Protein Sciences, saying the $78 million acquisition is "no longer practical." And in an announcement
Would-be partners wage angry feud
The angry exchanges between Emergent BioSolutions and Protein Sciences keep getting nastier. Both companies now accuse each other of breaking their $78 million merger pact, and the accusations are
Protein Sciences, Emergent wage war of words
Protein Sciences says it's terminated a $78 million deal to sell the company to Emergent BioSolutions, two weeks after the two developers launched into a messy public brawl over the merger. Emergent
Emergent accuses biotech execs of wrecking pact
Rockville, MD-based Emergent BioSolutions has filed suit against Protein Sciences, saying the vaccine developer never planned to follow through on a planned $75 million acquisition agreement.
Emergent accuses biotech execs of wrecking buyout pact
Rockville, MD-based Emergent BioSolutions has filed suit against Protein Sciences, saying the vaccine developer never planned to follow through on a planned $75 million acquisition agreement.
